Baxter Net Income 2010-2025 | BAX

Baxter annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Baxter net income for the quarter ending March 31, 2025 was $126M, a 240.54% increase year-over-year.
  • Baxter net income for the twelve months ending March 31, 2025 was $-0.560B, a 121.14% decline year-over-year.
  • Baxter annual net income for 2024 was $-0.649B, a 124.44% decline from 2023.
  • Baxter annual net income for 2023 was $2.656B, a 209.17% decline from 2022.
  • Baxter annual net income for 2022 was $-2.433B, a 289.49% decline from 2021.
Baxter Annual Net Income
(Millions of US $)
2024 $-649
2023 $2,656
2022 $-2,433
2021 $1,284
2020 $1,102
2019 $1,001
2018 $1,546
2017 $602
2016 $4,965
2015 $968
2014 $2,497
2013 $2,012
2012 $2,326
2011 $2,224
2010 $1,420
2009 $2,205
Baxter Quarterly Net Income
(Millions of US $)
2025-03-31 $126
2024-12-31 $-512
2024-09-30 $140
2024-06-30 $-314
2024-03-31 $37
2023-12-31 $245
2023-09-30 $2,508
2023-06-30 $-141
2023-03-31 $44
2022-12-31 $181
2022-09-30 $-2,937
2022-06-30 $252
2022-03-31 $71
2021-12-31 $238
2021-09-30 $450
2021-06-30 $298
2021-03-31 $298
2020-12-31 $168
2020-09-30 $356
2020-06-30 $246
2020-03-31 $332
2019-12-31 $-23
2019-09-30 $369
2019-06-30 $313
2019-03-31 $342
2018-12-31 $296
2018-09-30 $518
2018-06-30 $343
2018-03-31 $389
2017-12-31 $-186
2017-09-30 $251
2017-06-30 $265
2017-03-31 $272
2016-12-31 $243
2016-09-30 $130
2016-06-30 $1,212
2016-03-31 $3,380
2015-12-31 $205
2015-09-30 $1
2015-06-30 $332
2015-03-31 $430
2014-12-31 $953
2014-09-30 $468
2014-06-30 $520
2014-03-31 $556
2013-12-31 $326
2013-09-30 $544
2013-06-30 $590
2013-03-31 $552
2012-12-31 $494
2012-09-30 $583
2012-06-30 $661
2012-03-31 $588
2011-12-31 $463
2011-09-30 $576
2011-06-30 $615
2011-03-31 $570
2010-12-31 $423
2010-09-30 $525
2010-06-30 $535
2010-03-31 $-63
2009-12-31 $572
2009-09-30 $530
2009-06-30 $587
2009-03-31 $516
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.713B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.37
Boston Scientific (BSX) United States $147.560B 36.94
Stryker (SYK) United States $144.011B 30.11
EssilorLuxottica (ESLOY) France $128.708B 0.00
Medtronic (MDT) Ireland $111.928B 15.87
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.87
ResMed (RMD) United States $36.560B 27.46
Agilent Technologies (A) United States $33.258B 21.68
GE HealthCare Technologies (GEHC) United States $33.082B 15.71
Terumo (TRUMY) Japan $26.680B 34.65
Insulet (PODD) United States $21.438B 84.15
Koninklijke Philips (PHG) Netherlands $21.384B 15.37
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.60
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.54
Perrigo (PRGO) Ireland $3.664B 9.29
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.34
ICU Medical (ICUI) United States $3.250B 23.96
Envista Holdings (NVST) United States $3.127B 25.99
GN Store Nord (GNNDY) Denmark $2.263B 18.74
QuidelOrtho (QDEL) United States $1.954B 13.44
LeMaitre Vascular (LMAT) United States $1.833B 40.97
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.36
AdaptHealth (AHCO) United States $1.161B 11.78
Green Thumb Industries (GTBIF) United States $1.048B 23.58
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.40
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.51
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 4.99
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.41
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 58.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.52
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 5.82
Brainsway (BWAY) Israel $0.206B 54.50
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.59
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 0.00
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.64
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 55.29
United-Guardian (UG) United States $0.037B 12.90
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00